On May 19th, 2023, the 3rd 3D Cell Culture and Organoid Symposium was successfully held in Shanghai, and the "Huayi List • 2023 Organoid Industry Rising Star List" was officially announced at the conference. Hopstem was honored with the title of "Top 10 Organ Enterprises with the Most Investment Value"!
HopCell® human 3D cortical organoids are derived from human iPSCs, with relatively uniform size, shape, cell composition, and structure, as well as relatively mature electrophysiological functions. After about 90 days of cultivation, molecular markers of the six cortical layers of the brain, such as REELIN, CUX1, BRN2, SATB2, CTIP2, and TBR1, as well as intermediate neuron markers such as PV, nNOS, and SST, and astrocytes and oligodendrocytes, can be detected. It is currently the closest in vitro system to the human brain composition. HopCell® human 3D cortical organoids can be used as models for neurological diseases, drug screening, and toxicity testing. Business partners interested in brain organoid licensing cooperation are welcome to inquire.
Hopstem Biotechnology Received FDA Clearance of IND Application for hNPC01 in Chronic Ischemic Stroke
Hopstem Wins the Third Prize of VB-Link Competition
Huayi List: Hopstem Ranks Top 10 Most Promising Biotech Companies
The iPSC-derived Human Forebrain Neural Progenitor Cell Injection hNPC01 of Hopstem has Received CDE's Clinical Implication Approval